by Urška Mrgole | Feb 19, 2026 | Meet the Partners, News
Cosylab d.d. supports cutting-edge accelerator-based technologies worldwide—from Big Science facilities to advanced medical applications—and brings this same end-to-end expertise to IFIGENEIA’s work on radioisotope production and radiopharmaceuticals. Cosylab d.d. is...
by Urška Mrgole | Feb 16, 2026 | Events, News
IFIGENEIA is proud to be an organiser of a ten-day event, a challenge based on innovations for students – CBI, that will be held at the University of Sarajevo. The goal is to present an innovative idea on the use of accelerators in applications that benefit the...
by Urška Mrgole | Feb 13, 2026 | News
The IFIGENEIA project (Horizon Europe, WIDERA) aims to lay the foundations for significant advancements in the production and clinical application of radionuclides using linear accelerators (LINACs), thereby enhancing radiopharmaceutical development and availability...
by Urška Mrgole | Feb 9, 2026 | Meet the Partners, News
BIOKOSMOS MEDICAL SCIENTIFIC EQUIPMENT COMMERCIAL INDUSTRY SOCIETE ANONYME, (BIOKOSMOS SA, a pioneering Greek company in the field of radiopharmaceuticals and molecular imaging, brings decades of expertise, advanced technological infrastructure, and strong research...
by Urška Mrgole | Feb 3, 2026 | Meet the Partners, News
The University of Cyprus (UCY) is a major academic and research institution in the Eastern Mediterranean region, with a strong strategic role in advancing education, training, and capacity building within the IFIGENEIA project. Through its established excellence in...
